Isotretinoin Capsule, Liquid Filled
Product Images NDC 0245-0571

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Isotretinoin (NDC 0245-0571). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Upsher-smith Laboratories, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Isotretinoin 01)

FDA Label Image

Figure 1 (Isotretinoin 02)

Figure 1 (Isotretinoin 02)
This is a chart showing the mean lesion count over a period of 20 weeks while using Isotretinoin Capsules. There are values for baseline, week 4, week 8, week 12, week 16, and week 20. There were no lesions observed in the analysis visit.*
FDA Label Image

Principal Display Panel (10 mg Capsule Blister Pack Box)

Principal Display Panel (10 mg Capsule Blister Pack Box)
This is a label for isotretinoin capsules, USP, which are available in 10 mg strength. The capsules are only available on prescription and the pharmacist should dispense them intact in 30-day supplies. They are contraindicated during pregnancy and the entire PLEDGE program has to be followed for dispensing. The recommended storage temperature is 20°C to 25°C. Pharmacists should refer to the accompanying insert for dosage recommendations and other important prescribing information. The manufacturer is Upsher Smith Laboratories, and the product is protected from light.*
FDA Label Image

Principal Display Panel (20 mg Capsule Blister Pack Box)

Principal Display Panel (20 mg Capsule Blister Pack Box)
This is a description of Isotretinoin, a medicine that comes in capsules with 20mg of the active ingredient. It is contraindicated in pregnancy and can cause birth defects. The text includes special instructions for pharmacists and reminders for dispensing the prescription packs intact. There is a packaging code and a contact for the manufacturer. However, there is no clear indication of what condition the medicine is used to treat.*
FDA Label Image

Principal Display Panel (30 mg Capsule Blister Pack Box)

Principal Display Panel (30 mg Capsule Blister Pack Box)
This is a description of Isotretinoin capsules, USP with a strength of 30 mg. This medication is only available with a prescription, and it is contraindicated for use during pregnancy. The usual dosage and prescribing information can be found in the accompanying insert. The medication must be stored between 20°C to 25°C and protected from light. Special instructions are provided for dispensing prescription packs.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.